Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Spark Therapeutics Inc (ONCE) USD0.001

Sell:$111.11 Buy:$111.16 Change: $0.49 (0.44%)
NASDAQ:0.40%
Market closed |  Prices as at close on 9 December 2019 | Switch to live prices |
Tender Offer

Spark Therapeutics Inc USD0.001

Type:
Tender Offer
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 6 Dec 2019)

What is happening?

 

As you may be aware the Boards of Spark Therapeutics Inc and Roche Holdings AG have recently announced the terms of a Tender Offer for Roche Holdings AG to purchase up to the entire issued Share Capital of Spark Therapeutics Inc. Under the terms of the Tender Offer holders of Spark Therapeutics Inc Shares have been offered USD114.50 for each Share held.

 

What are my options?

 

Option 1 – Do nothing. You are not required to take any action at this time.

 

Option 2 – Accept the Offer. You can give an instruction to accept the Tender Offer of USD114.50 for each Spark Therapeutics Share held. Following receipt of your instruction your Shares would be submitted in acceptance of the Offer.

 

Any instruction must be received in this office by 8.00am Monday 9th December 2019. If no instruction is received, your Shares will not be tendered and the Offer will lapse.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown Clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:$111.11
Buy:$111.16
Change: $0.49 (0.44%)
Market closed |  Prices as at close on 9 December 2019 | Switch to live prices |
Tender Offer

Spark Therapeutics Inc USD0.001

Type:
Tender Offer
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 6 Dec 2019)

What is happening?

 

As you may be aware the Boards of Spark Therapeutics Inc and Roche Holdings AG have recently announced the terms of a Tender Offer for Roche Holdings AG to purchase up to the entire issued Share Capital of Spark Therapeutics Inc. Under the terms of the Tender Offer holders of Spark Therapeutics Inc Shares have been offered USD114.50 for each Share held.

 

What are my options?

 

Option 1 – Do nothing. You are not required to take any action at this time.

 

Option 2 – Accept the Offer. You can give an instruction to accept the Tender Offer of USD114.50 for each Spark Therapeutics Share held. Following receipt of your instruction your Shares would be submitted in acceptance of the Offer.

 

Any instruction must be received in this office by 8.00am Monday 9th December 2019. If no instruction is received, your Shares will not be tendered and the Offer will lapse.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown Clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:$111.11
Buy:$111.16
Change: $0.49 (0.44%)
Market closed |  Prices as at close on 9 December 2019 | Switch to live prices |
Tender Offer

Spark Therapeutics Inc USD0.001

Type:
Tender Offer
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 6 Dec 2019)

What is happening?

 

As you may be aware the Boards of Spark Therapeutics Inc and Roche Holdings AG have recently announced the terms of a Tender Offer for Roche Holdings AG to purchase up to the entire issued Share Capital of Spark Therapeutics Inc. Under the terms of the Tender Offer holders of Spark Therapeutics Inc Shares have been offered USD114.50 for each Share held.

 

What are my options?

 

Option 1 – Do nothing. You are not required to take any action at this time.

 

Option 2 – Accept the Offer. You can give an instruction to accept the Tender Offer of USD114.50 for each Spark Therapeutics Share held. Following receipt of your instruction your Shares would be submitted in acceptance of the Offer.

 

Any instruction must be received in this office by 8.00am Monday 9th December 2019. If no instruction is received, your Shares will not be tendered and the Offer will lapse.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown Clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Open:
$110.84
Trade high:
$111.63
Year high:
$114.20
Market capitalisation
Market cap.
:
$4.26 bn
Previous close:
$110.65
Trade low:
$110.84
Year low:
$34.59
Shares in issue
Shares
:
38.52 m
Previous:
$0.97 (0.88%)
Previous:
$0.97
Volume:
n/a
Dividend yield:
n/a
Currency:
USD
Data delayed by at least 15 minutes.
* To buy US shares you must first complete and return a US government ‘W-8BEN’ form.

Ready to invest?

To buy shares in , you'll need to have an account. Try our handy filter to explore the different options.

Compare accounts

Ready to take your first step?

To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.

Compare accounts

Important Documents

There are no documents available for this stock.

Dividend information for this stock is not available.

Dividend information for this stock is not available.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by Reuters. Charts provided by Factset. 'Broker forecast' and 'Recent trades' provided by MoneyAM. News and fundamental data provided by Digital Look. Exchange disclaimer

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.